IL-10 reduces rat brain injury following focal stroke

Neuroscience Letters

Volumn 251, Issue 3, 1998, Pages 189-192

  Spera, Patricia A ^a   Ellison, Julie A ^a   Feuerstein, Giora Z ^a   Barone, Frank C ^a  

^a SmithKline Beecham P ^*  (United States)

Author keywords

Brain injury; Cerebral ischemia; Cytokines; Focal stroke; IL 10; Inflammation; Neuroprotection

Indexed keywords

RECOMBINANT INTERLEUKIN 10;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOMODULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CEREBRAL INFARCTION; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-10; ISCHEMIC ATTACK, TRANSIENT; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED SHR; RECOMBINANT PROTEINS;

EID: 0032584685     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00537-0     Document Type: Article

References (20)

1. Balasingam V., Young V.W. Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 16:1996;2945-2955.
2. Barone F., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 28:1997;1233-1244.
3. Barone F., Price W., White R., Willette R., Feuerstein G. Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci. Biobehav. Rev. 16:1992;219-233.
4. Berkman N., John M., Roesems G., Jose P.J., Barnes P.J., Chung K.F. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J. Immunol. 155:1995;4412-4418.
5. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., deVries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 reduced by monocytes. J. Exp. Med. 174:1991;1209-1220.
6. Engles R.E., Huber T.S., Zander D.S., Hess P.J., Burress Welborn M., Moldawer L.L., Seeger J.M. Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. J. Surg. Res. 69:1997;425-428.
7. Eppinger M.J., Ward P.A., Bolling S.F., Beeb G.M. Regulatory effects of interleukin-10 on lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 112:1996;1301-1306.
8. Feuerstein, G.Z., Wang, X.K. and Barone, F., Inflammatory mediators and brain injury: the role of cytokine and chemokines in stroke and CNS diseases. In M. Ginsberg and J. Bogousslavsky (Eds.), Chp. 36, Blackwell Science, MA, 1998, pp. 507-531.
9. Geng Y., Gulbins E., Altman A., Lotz M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. USA. 91:1994;8602-8606.
10. Hayward R., Nossuli T.O., Scalia R., Lefer A.M. Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion. Eur. J. Pharmacol. 334:1997;157-163.
11. Hess P.J., Seeger J.M., Huber T.S., Welborn M.B., Martin R.D., Harward T.R., Duschek S., Edwards P.D., Solorzano C.C., Copeland E.M., Moldawer L.L. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model or acute visceral ischemia. J. Vasc. Surg. 26:1997;113-118.
12. Howard M., O'Garra A. Biological properties of interleukin 10. Immunol. Today. 13:1992;198-200.
13. Huhn R., Radwanski E., O'Connell S., Sturgill M., Clarke L., Cody R., Affrine M., Cutler D. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood. 87:1996;699-705.
14. Jiang N., Finklestein S.P., Do T., Caday C.G., Charette M., Chopp M. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J. Neurol. Sci. 139:1996;173-179.
15. Kochanek P.M., Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 23:1992;1367-1379.
16. Knoblack, S. and Faden, A., Interleukin-10 improves outcome and suppresses proinflammatory cytokine expression after traumatic brain injury, Soc. Neurosci. Abstr. (27th Annual Meeting), 23(1) (1997) 268.
17. Rothwell N., Allan S., Troulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100:1997;2648-2652.
18. Shrikant P., Weber E., Jilling T., Benveniste E.N. Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6. J. Immunol. 155:1995;1489-1501.
19. Swanson R.A., Moreton M.T., Tsao-Wu G., Salvalos R.H., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10:1990;290-293.
20. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:1995;9558-9563.